LabCorp, Quest Broaden Availability of COVID-19 Tests Nationwide
05/14/2020
The U.S. clinical testing giants Quest Diagnostics and LabCorp are broadening the availability of their COVID-19 diagnostic tests, opening up their use nationwide, according to a FierceBiotech report.
Initially, LabCorp’s at-home test collection kit, which allows people to ship their own nasal swab samples to the lab to be checked for an active infection, was first made available to healthcare workers and first responders through the company’s online platform, after being authorized by the FDA last month.